Literature DB >> 24320797

Comparison of antimicrobial susceptibility among Clostridium difficile isolated from an integrated human and swine population in Texas.

Keri N Norman1, Harvey M Scott, Roger B Harvey, Bo Norby, Michael E Hume.   

Abstract

Clostridium difficile can be a major problem in hospitals because the bacterium primarily affects individuals with an altered intestinal flora; this largely occurs through prolonged antibiotic use. Proposed sources of increased community-acquired infections are food animals and retail meats. The objective of this study was to compare the antimicrobial resistance patterns of C. difficile isolated from a closed, integrated population of humans and swine to increase understanding of the bacterium in these populations. Swine fecal samples were collected from a vertically flowing swine population consisting of farrowing, nursery, breeding, and grower/finisher production groups. Human wastewater samples were collected from swine worker and nonworker occupational group cohorts. Antimicrobial susceptibility testing was performed on 523 C. difficile strains from the population using the commercially available agar diffusion Epsilometer test (Etest(®)) for 11 different antimicrobials. All of the swine and human strains were susceptible to amoxicillin/clavulanic acid, piperacillin/tazobactam, and vancomycin. In addition, all of the human strains were susceptible to chloramphenicol. The majority of the human and swine strains were resistant to cefoxitin and ciprofloxacin. Statistically significant differences in antimicrobial susceptibility were found among the swine production groups for ciprofloxacin, tetracycline, amoxicillin/clavulanic acid, and clindamycin. No significant differences in antimicrobial susceptibility were found across human occupational group cohorts. We found that 8.3% of the swine strains and 13.3% of the human strains exhibited resistance to metronidazole. The finding of differences in susceptibility patterns between human and swine strains of C. difficile provides evidence that transmission between host species in this integrated population is unlikely.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24320797     DOI: 10.1089/fpd.2013.1648

Source DB:  PubMed          Journal:  Foodborne Pathog Dis        ISSN: 1535-3141            Impact factor:   3.171


  8 in total

Review 1.  Update on Antimicrobial Resistance in Clostridium difficile: Resistance Mechanisms and Antimicrobial Susceptibility Testing.

Authors:  Zhong Peng; Dazhi Jin; Hyeun Bum Kim; Charles W Stratton; Bin Wu; Yi-Wei Tang; Xingmin Sun
Journal:  J Clin Microbiol       Date:  2017-04-12       Impact factor: 5.948

Review 2.  Recent advances in the understanding of antibiotic resistance in Clostridium difficile infection.

Authors:  Patrizia Spigaglia
Journal:  Ther Adv Infect Dis       Date:  2016-02

Review 3.  Clostridium difficile: Diagnosis and the Consequence of Over Diagnosis.

Authors:  Helen S Lee; Kamryn Plechot; Shruti Gohil; Jennifer Le
Journal:  Infect Dis Ther       Date:  2021-03-26

4.  Surveillance of Antibiotic Resistance among Hospital- and Community-Acquired Toxigenic Clostridium difficile Isolates over 5-Year Period in Kuwait.

Authors:  Wafaa Y Jamal; Vincent O Rotimi
Journal:  PLoS One       Date:  2016-08-18       Impact factor: 3.240

Review 5.  Conventional and alternative treatment approaches for Clostridium difficile infection.

Authors:  Khalid M Aljarallah
Journal:  Int J Health Sci (Qassim)       Date:  2017 Jan-Mar

Review 6.  Clostridium difficile Infections: A Global Overview of Drug Sensitivity and Resistance Mechanisms.

Authors:  Saeed S Banawas
Journal:  Biomed Res Int       Date:  2018-02-21       Impact factor: 3.411

7.  Successional Dynamics in the Gut Microbiome Determine the Success of Clostridium difficile Infection in Adult Pig Models.

Authors:  Stephanie D Jurburg; Jan J B W J Cornelissen; Paulo de Boer; Mari A Smits; Johanna M J Rebel
Journal:  Front Cell Infect Microbiol       Date:  2019-08-06       Impact factor: 5.293

Review 8.  Anti-virulence strategies for Clostridioides difficile infection: advances and roadblocks.

Authors:  David Stewart; Farhan Anwar; Gayatri Vedantam
Journal:  Gut Microbes       Date:  2020-11-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.